Studies of the role of opioids in control of human pancreatic secretion
- 25 Downloads
- 7 Citations
Abstract
Opioids, both endogenous and exogenous, have been shown to exert a modulating influence on many gastrointestinal functions. Animal studies suggest an inhibitory role for opioids in the control of pancreatic secretion, which may be exerted through their inhibitory effect on acetylcholine release from intramural neurons. We studied pancreatic secretion in six healthy male volunteers (mean age 42 years) by means of duodenal aspiration using PEG-4000 as a recovery marker. Pancreatic secretion was stimulated with duodenal perfusion of mannitol (510 mosmol/kg) and an equimolar solution (0.3 M/liter) ofl-phenylalanine andl-tryptophan and also with an intravenous bolus of secretin and cholecystokinin (each 1 CU/kg). Each subject underwent six studies on separate days with intravenous infusion of saline, naloxone 40 Μg/kg/hr, morphine sulfate 40 Μg/kg/hr, morphine and naloxone combined, naloxone and atropine 13 Μg/kg/hr, and morphine and bethanechol 16 Μg/kg/hr. Naloxone caused a significant increase in amylase outputs during the basal period and in response to all stimuli, without affecting bicarbonate outputs. This effect was blocked by atropine. Morphine caused significant reductions in both amylase and bicarbonate outputs with all stimuli. This was accompanied by a reduction in amylase concentrations but not in those of bicarbonate. Bethanechol counteracted these effects of morphine. The combination of morphine and naloxone had no significant effect on pancreatic secretion. Changes in pancreatic polypeptide levels did not explain the observations. In conclusion, these studies suggest that endogenous opioids exert a modulating influence on human pancreatic secretion. Morphine has a significant inhibitory effect on enzyme output as in animal studies. These effects may be mediated through an effect on acetylcholine release from nerve terminals and an interaction with cholecystokinin.
Key words
pancreatic secretion opioids human pancreas morphinePreview
Unable to display preview. Download preview PDF.
References
- 1.Polak JM, Sullivan SN, Bloom SR, Facer P, Pearse AGE: Enkephalin-like immunoreactivity in the human gastrointestinal tract. Lancet 1:972–974, 1977Google Scholar
- 2.Konturek SJ: Endogenous opiates and the digestive system. Scand J Gastroenterol 13:257–261, 1978Google Scholar
- 3.Bruni JF, Watkins WB, Yen SSC: Endorphin in the human pancreas. J Clin Endocrinol Metab 49:649–651, 1979Google Scholar
- 4.Miller RJ, Brown DR: Opiates and the gut. Viewpoints Dig Dis 16:5–8, 1984Google Scholar
- 5.Stranghellini V, Malagelada JR, Zinsmeister AR, Go VLW, Kao PC: Stress induced gastroduodenal motor disturbances in humans: Possible humoral mechanisms. Gastroenterology 85:83–91, 1983Google Scholar
- 6.Kinsman RI, Read NW: Effect of naloxone on feedback regulation of small bowel transit by fat. Gastroenterology 87:335–337, 1984Google Scholar
- 7.Feldman M, Walsh JH, Taylor IL: Effect of naloxone and morphine on gastric acid secretion and on serum gastrin and pancreatic polypeptide in humans. Gastroenterology 97:294–298, 1980Google Scholar
- 8.Konturek SJ, Tasler J, Cieszkowski M, Jaworek J, Coy DH, Schally AV: Inhibition of pancreatic secretion by enkephalin and morphine in dogs. Gastroenterology 74:851–858, 1978Google Scholar
- 9.Roze C, Dubrasquet M, Chariot J, Vaille C: Central inhibition of basal pancreatic and gastric secretions by Β-endorphin in rats. Gastroenterology 79:659–664, 1980Google Scholar
- 10.Roze C, Dubrasquet M, Chariot J, Vaille C: Methadone inhibition of vagally induced pancreatic and gastric secretions in rats: Central and peripheral sites of action. Eur J Pharmacol 78:271–278, 1982Google Scholar
- 11.Gullo L, Priori P, Costa PL, Garcea D, Baldoni F, Mattioli G, Labo G: Effects of morphine on human pancreatic secretion: Studies on pure pancreatic juice. Gut 23:739–743, 1982Google Scholar
- 12.Solomon TE, Grossman MI: Effect of atropine and vagotomy on response of transplanted pancreas. Am J Physiol 236:E186-E190, 1979Google Scholar
- 13.Singer MV, Solomon TE, Grossman MI: Effect of atropine on secretion from intact and transplanted pancreas in dog. Am J Physiol 238:G18-G22, 1980Google Scholar
- 14.Paton WDM: The action of morphine and related substances on contraction and on acetylcholine output of coaxially stimulated guinea pig ileum. Br J Pharmacol Chemother 12:119–127, 1957Google Scholar
- 15.Cox BM, Weinstock M: The effect of analgesic drugs on the release of acetylcholine from electrically stimulated guinea pig ileum. Br J Pharmacol Chemother 27:81–92, 1966Google Scholar
- 16.Jhamadas K, Pinsky C, Phillis JW: Effects of morphine and its antagonists on release of cerebral cortical acetylcholine. Nature 228:176–177, 1970Google Scholar
- 17.Yau WM, Lingle PF, Youther ML: Interaction of enkephalin and caerulein on guinea pig small intestine. Am J Physiol 244:G65-G70, 1983Google Scholar
- 18.Faris PL, Komisaruk BR, Watkins LR, Mayer DJ: Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia. Science 219:310–312, 1983Google Scholar
- 19.Valenzuela JE, Weiner K, Saad C: Cholinergic stimulation of human pancreatic secretion. Dig Dis Sci 31:615–619, 1986Google Scholar
- 20.Dooley CP, Valenzuela JE: Duodenal volume and osmoreceptors in the stimulation of human pancreatic secretion. Gastroenterology 86:23–27, 1984Google Scholar
- 21.Mazzuchin A, Weggel C, Porter CJ: Automated method for determining amylase activity in serum and urine. Clin Chem 19:1187–1192, 1973Google Scholar
- 22.Hyden S: A turbidimetric method for the determination of higher polyethylene glycols in biological materials. Lantbruksirogst Ann 22:139–145, 1955Google Scholar
- 23.Taylor IL, Feldman M, Richardson CT, Walsh JH: Gastric and cephalic stimulation of human pancreatic polypeptide release. Gastroenterology 75:432–437, 1978Google Scholar
- 24.Hallenbeck GA: Biliary and pancreatic intraductal pressures.In Handbook of Physiology, Section 6: Alimentary Canal, Vol. 2 CF Code (ed). Washington, DC, American Physiological Society, 1967, pp 1007–1025.Google Scholar
- 25.Konturek SJ, Tasler J, Pawlik W, Thor P, Walus K, Coy D, Schally AV: Effects of enkephalin on the gastrointestinal tract. Symposium on Hormones and Gut. Lausanne, Switzerland, 1977, SJ Konturek (ed). London, Churchill Livingstone, pp 132–146.Google Scholar
- 26.Gardner JD, Conlon TP, Klaeveman HL, Adams TD, Ondetti MA: Action of cholecystokinin and cholinergic agents on calcium transport in isolated pancreatic acinar cells. J Clin Invest 56:366–375, 1975Google Scholar
- 27.Watkins LB, Kinscheck IB, Mayer DJ: Potentiation of opiate analgesia and apparent reversal of morphine tolerance by proglumide. Science 224:395–396, 1984Google Scholar
- 28.Taylor IL, Solomon TE, Walsh JH, Grossman MI: Pancreatic polypeptide. Metabolism and effect on pancreatic secretion in dogs. Gastroenterology 76:524–528, 1979Google Scholar
- 29.Taylor IL, Feldman M, Richardson CT, Walsh JH: Gastric and cephalic stimulation of human pancreatic polypeptide release. Gastroenterology 75:432–437, 1978Google Scholar
- 30.Modlin IM, Albert D, Crochelt R, Sank A, Jaffee BM: Evidence for an intestinal mechanism of pancreatic polypeptide release. Dig Dis Sci 26:587–590, 1981Google Scholar
- 31.Walsh JH: Endocrine cells of the digestive system.In Physiology of the Gastrointestinal Tract. LR Johnson (ed). New York, Raven Press, 1981, pp 117–123Google Scholar
- 32.Adrian TE, Besterman HS, Bloom SR: The importance of cholinergic tone in the release of pancreatic polypeptide by gut hormones in man. Life Sci 24:1989–1994, 1979Google Scholar